Metformin ER 500mg 24hr Tabs
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. Take your medication with meals as directed. Continue taking your medication as prescribed by your doctor or healthcare provider, even if you feel well. If you are taking this medication once daily, take it with your evening meal. Swallow the tablet whole; do not chew, break, or crush it. If you have difficulty swallowing, consult your doctor.
Storing and Disposing of Your Medication
Store your medication at room temperature, protected from light, and in a dry place. Avoid storing it in a bathroom. Keep all medications in a safe location, out of the reach of children and pets.
Missing a Dose
If you miss a dose, skip it and resume your regular dosing schedule unless your doctor instructs you to do otherwise. Do not take two doses at the same time or take extra doses.
Lifestyle & Tips
- Maintain a healthy diet as recommended by your doctor or dietitian.
- Engage in regular physical activity as advised by your healthcare provider.
- Limit alcohol intake, as excessive alcohol can increase the risk of a serious side effect called lactic acidosis.
- Monitor your blood sugar levels regularly as instructed by your doctor.
Available Forms & Alternatives
Available Strengths:
- Metformin 1000mg Tablets
- Metformin 500mg Tablets
- Metformin 850mg Tablets
- Metformin ER 500mg 24hr Tabs
- Metformin ER 750mg 24hr Tabs
- Metformin ER 500mg Modified Tabs
- Metformin ER 1000mg Modified Tabs
- Metformin ER 500mg 24hr Tabs
- Metformin ER 500mg Osmotic Tabs
- Metformin ER 1000mg Osmotic Tabs
- Metformin ER 750mg 24hr Tabs
- Metformin ER 500mg Modified Tabs
- Metformin ER 1000mg Modified Tabs
- Metformin 500mg/5ml Solution
- Metformin 625mg Tablets
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Stomach problems that occur later during treatment, which may be a sign of lactic acidosis (an acid health problem in the blood)
Low blood sugar, which can be characterized by:
+ Dizziness
+ Headache
+ Feeling sleepy or weak
+ Shaking
+ Fast heartbeat
+ Confusion
+ Hunger
+ Sweating
If you experience any of these symptoms, call your doctor right away. For low blood sugar, follow your doctor's instructions, which may include taking glucose tablets, liquid glucose, or some fruit juices.
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. Contact your doctor or seek medical help if you experience any of the following side effects or if they bother you or do not go away:
Stomach pain or heartburn
Gas
Diarrhea, upset stomach, or vomiting
Feeling tired or weak
Headache
This is not an exhaustive list of possible side effects. If you have questions or concerns, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Symptoms of lactic acidosis: unusual muscle pain, trouble breathing, unusual sleepiness, stomach pain, nausea, vomiting, feeling cold, dizziness, lightheadedness, or a slow or irregular heartbeat. Seek immediate medical attention if these occur.
- Symptoms of low blood sugar (hypoglycemia) if taken with other diabetes medications: sweating, shaking, fast heartbeat, hunger, blurred vision, dizziness, tingling hands/feet.
- Symptoms of Vitamin B12 deficiency: unusual tiredness, weakness, numbness or tingling in hands or feet.
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
Certain health conditions, including:
+ Acidic blood problems
+ Kidney disease
+ Liver disease
Recent medical events, such as a heart attack or stroke
Any difficulties with eating or drinking, including situations where you may be required to fast before a procedure or surgery
* Upcoming or recent exams or tests that involve contrast agents, particularly if they have taken place within the past 48 hours
This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. They will help determine if it is safe to take this medication in conjunction with your other treatments and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
Precautions & Cautions
If you experience low blood sugar, do not operate a vehicle, as this can increase your risk of being involved in an accident. Monitor your blood sugar levels as directed by your doctor. Additionally, follow your doctor's instructions for regular blood work check-ups and discuss the results with them.
Be aware that stress, such as fever, infection, injury, or surgery, can affect your blood sugar control. Changes in physical activity, exercise, or diet can also impact your blood sugar levels. Adhere to the diet and exercise plan recommended by your doctor to maintain optimal blood sugar control.
If you experience diarrhea or vomiting, contact your doctor promptly, as you may need to increase your fluid intake to prevent excessive fluid loss. In hot weather or during physical activity, be cautious and drink plenty of fluids to avoid dehydration.
Long-term treatment with metformin may lead to a decrease in vitamin B-12 levels. If you have a history of low vitamin B-12 levels, consult with your doctor. You may notice the appearance of a tablet in your stool, but this is a normal occurrence and not a cause for concern. If you have any questions or concerns, discuss them with your doctor.
If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects. Women of childbearing age who have not been ovulating may experience a return of fertility while taking this medication. To avoid pregnancy, use birth control measures while taking this drug.
If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor, as they will need to discuss the potential benefits and risks of this medication to you and your baby.
Overdose Information
Overdose Symptoms:
- Lactic acidosis (most serious and common symptom)
- Hypoglycemia (less common with metformin alone, but possible with very large overdose or in combination with other agents)
- Gastrointestinal upset (nausea, vomiting, diarrhea)
What to Do:
Call 911 or Poison Control (1-800-222-1222) immediately. Treatment for lactic acidosis involves supportive measures and prompt hemodialysis to remove metformin and correct acidosis.
Drug Interactions
Contraindicated Interactions
- Iodinated contrast media (temporarily discontinue metformin at the time of or prior to the procedure in patients with an eGFR between 30 and 60 mL/min/1.73 m2; in patients with a history of liver disease, alcoholism, or heart failure; or in patients who will be administered intra-arterial iodinated contrast. Re-evaluate eGFR 48 hours after the imaging procedure; restart metformin only if renal function is stable.)
- Severe renal impairment (eGFR <30 mL/min/1.73m²)
- Acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma.
Major Interactions
- Alcohol (potentiates the effect of metformin on lactate metabolism, increasing risk of lactic acidosis)
- Carbonic anhydrase inhibitors (e.g., topiramate, zonisamide, acetazolamide, dichlorphenamide) - may increase risk of lactic acidosis
- Cimetidine (increases metformin plasma concentration by reducing renal clearance)
Moderate Interactions
- Drugs that reduce metformin clearance (e.g., ranolazine, vandetanib, dolutegravir, cimetidine, isavuconazole, trimethoprim, cimetidine, verapamil, rifampin, cimetidine, quinidine, procainamide, amiloride, triamterene, furosemide, digoxin, morphine, probenecid, nifedipine) - may increase metformin levels and risk of lactic acidosis.
- Drugs that affect glycemic control (e.g., thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, isoniazid) - may cause hyperglycemia, requiring metformin dose adjustment.
- Sulfonylureas or insulin (increased risk of hypoglycemia when used concomitantly)
Minor Interactions
- Not available (most interactions are moderate to major due to potential for lactic acidosis or altered glucose control)
Monitoring
Baseline Monitoring
Rationale: To assess baseline kidney function and determine appropriate dosing or contraindication.
Timing: Prior to initiation of therapy.
Rationale: To establish baseline glycemic control.
Timing: Prior to initiation of therapy.
Rationale: To establish baseline glycemic control.
Timing: Prior to initiation of therapy.
Routine Monitoring
Frequency: Every 3-6 months
Target: <7% (individualized)
Action Threshold: >7% (consider dose adjustment or additional therapy)
Frequency: At least annually; more frequently (e.g., every 3-6 months) in patients at risk for renal impairment (elderly, those with comorbidities) or when initiating interacting drugs.
Target: >60 mL/min/1.73m² (ideal for full dose)
Action Threshold: <45 mL/min/1.73m² (consider dose reduction or discontinuation); <30 mL/min/1.73m² (contraindicated)
Frequency: Periodically, as needed for glycemic control assessment.
Target: 80-130 mg/dL (individualized)
Action Threshold: Consistently outside target range (consider dose adjustment or additional therapy)
Frequency: Periodically (e.g., annually or every 2-3 years), especially in patients with risk factors for deficiency or symptoms.
Target: Normal range
Action Threshold: Low levels (consider supplementation)
Symptom Monitoring
- Symptoms of lactic acidosis: malaise, myalgia, unusual somnolence, respiratory distress, abdominal distress, increased somnolence, hypothermia, hypotension, resistant bradyarrhythmias. Patients should be instructed to seek immediate medical attention if these symptoms occur.
- Symptoms of hypoglycemia (if used with insulin or sulfonylureas): sweating, tremor, dizziness, confusion, hunger, irritability.
- Symptoms of Vitamin B12 deficiency: peripheral neuropathy, anemia, fatigue.
Special Patient Groups
Pregnancy
Metformin is not approved for use in pregnancy by the FDA, but clinical guidelines (e.g., ACOG, ADA) suggest it may be considered in some cases of gestational diabetes or type 2 diabetes in pregnancy, particularly when insulin is not feasible or acceptable. Insulin is generally preferred for glycemic control during pregnancy. Risk vs. benefit should be carefully weighed.
Trimester-Specific Risks:
Lactation
Metformin is excreted into breast milk in low amounts. It is generally considered compatible with breastfeeding (Lactation Risk Category L2).
Pediatric Use
Metformin IR is approved for children 10 years and older with type 2 diabetes. Metformin ER is not typically recommended or approved for pediatric use due to limited studies and different dosing considerations.
Geriatric Use
Use with caution due to increased likelihood of decreased renal function in elderly patients. Renal function should be assessed more frequently. Start with a lower dose and titrate slowly to minimize adverse effects and lactic acidosis risk.
Clinical Information
Clinical Pearls
- Metformin is considered first-line pharmacologic therapy for type 2 diabetes, especially in overweight or obese patients, due to its efficacy, low risk of hypoglycemia (when used alone), and potential for weight neutrality or modest weight loss.
- Always take Metformin ER with the evening meal to optimize absorption and reduce gastrointestinal side effects.
- Patients should be educated on the symptoms of lactic acidosis and instructed to seek immediate medical attention if they occur.
- Regular monitoring of renal function is crucial, especially before initiation, annually, and whenever conditions that may affect renal function (e.g., dehydration, new medications) arise.
- Periodic monitoring of Vitamin B12 levels is recommended, as long-term metformin use can be associated with B12 deficiency.
- Temporarily discontinue metformin before or at the time of iodinated contrast imaging procedures and certain surgical procedures.
Alternative Therapies
- Sulfonylureas (e.g., Glipizide, Glyburide)
- Thiazolidinediones (TZDs) (e.g., Pioglitazone)
- DPP-4 Inhibitors (e.g., Sitagliptin, Saxagliptin)
- SGLT2 Inhibitors (e.g., Canagliflozin, Dapagliflozin, Empagliflozin)
- GLP-1 Receptor Agonists (e.g., Liraglutide, Semaglutide, Dulaglutide)
- Insulin
- Alpha-glucosidase inhibitors (e.g., Acarbose)
- Meglitinides (e.g., Repaglinide)